James H. Mackaness, CHIEF FINANCIAL OFFICER at SOLENO THERAPEUTICS INC (SLNO), sold 29,167 shares at $45.89 ($1.3M) on 2024-08-06, disclosed to the SEC on 2024-08-07.
Open-market sale of $1.3M SLNO by CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.48 | 3,858 | $175K | 13.2% |
| 2 | $45.48 | 3,858 | $175K | 13.2% |
| 3 | $46.14 | 2,991 | $138K | 10.4% |
| 4 | $46.14 | 2,991 | $138K | 10.4% |
| 5 | $43.64 | 799 | $35K | 2.6% |
| 6 | $45.25 | 2,699 |
| $122K |
| 9.2% |
| 7 | $45.25 | 2,699 | $122K | 9.2% |
| 8 | $45.89 | 4,636 | $213K | 16.0% |
| 9 | $45.89 | 4,636 | $213K | 16.0% |
| Total | $45.65 avg | 29,167 | $1.3M | 100% |
| Filing → |
| SLNO | SELL | 2024-10-03 | $757K | — | Filing → |
| SLNO | SELL | 2024-08-30 | $1.1M | — | Filing → |
| SLNO | SELL | 2024-07-03 | $597K | — | Filing → |